Tetherex Pharmaceuticals Corporation

OKLAHOMA CITY, OK 73104

SBIR Award Summary

Total Number of Awards 1
Total Value of Awards $966K
First Award Date 08/01/17
Most Recent Award Date 08/01/17

Key Personnel

Last Name Name Awards Contact
ROLLINS SCOTT A ROLLINS 1

1 Award Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-080
Budget: 08/01/17 - 08/31/17

Project Abstract The primary objective of this proposal is to develop and commercialize a safe and more effective therapy for the treatment of Crohn's Disease, an inflammatory bowel disease. Crohn's Disease is a chronic inflammatory disorder of the gastrointestinal tract that affects some 500,000 patients in the US. Selexys Pharmaceuticals is de...